Product
Placebo + SOC
2 clinical trials
2 indications
Indication
COVID-19 pneumoniaIndication
COVID-19Clinical trial
A Pragmatic Adaptive Randomized, Controlled Phase II/III Multicenter Study of IFX-1 in Patients With Severe COVID-19 PneumoniaStatus: Completed, Estimated PCD: 2021-10-31
Clinical trial
Phase 3, Randomized, Placebo Controlled, Double-blind, Multicenter, Stratified Study of CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 PatientsStatus: Terminated, Estimated PCD: 2021-08-18